Upload Avatar (500 x 500)
Wei Xu
Basic Medical Sciences
Fudan University
Shanghai
Language: Chinese, English
Biomedicine
Virus Fusion
Inhibition
Emerging Viruses
Re-Emerging Viruses
Viral Infections
Hiv
Influenza
Covid-19
Pathogen Biology
Areas of Focus
- Biomedicine, Virus Fusion/Inhibition of Emerging and Re-emerging Viral Infections
Work Experience
- 2007.08—2011.07 - Taizhou Hospital, Zhejiang Province - Role not specified
- 2014.08—2016.09 - Shanghai Center for Disease Control and Prevention - Role not specified
- 2016.10—2019.10 - Postdoctoral Researcher, School of Basic Medical Sciences, Fudan University
- 2019.11—Present - Assistant Researcher, School of Basic Medical Sciences, Fudan University
Academic Background & Achievements
- 1999.09—2004.07 Bachelor's Degree in Medical Laboratory Science: Beihua University
- 2004.09—2007.07 Master's Degree in Clinical Laboratory Science: Beihua University
- 2011.09—2014.07 Ph.D. in Pathogen Biology: Fudan University
Publications
- A protein-based, long-acting HIV-1 fusion inhibitor with an improved pharmacokinetic profile, Xu W#, Cong Z#, Duan Q#, Wang Q, Su S, Wang R, Lu L*, Xue J*, Jiang S*, 2022
- A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life, Duan Q, Xia S, Jiao F, Wang Q, Wang R, Lu L*, Jiang S*, Xu W*, 2022
- A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs, Liu Z#, Zhou J#, Xu W#, Deng W#, Wang Y#, Wang M#, Wang Q, Hsieh M, Dong J, Wang X, Huang W, Xing L, He M, Tao C, Xie Y, Zhang Y*, Wang Y*, Zhao J*, Yuan Z*, Qin C*, Jiang S*, Lu L*, 2022
- Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection, Xu W, Su S, Jiang S, 2021
- Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41, Xu W, Pu J, Su S, Hua C, Su X, Wang Q, Jiang S*, Lu L*, 2019
- IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies, Bi W#, Xu W#, Cheng L, Xue J, Wang Q, Yu F, Xia S, Wang Q, Li G, Qin C, Lu L*, Su L*, Jiang S*, 2019
- The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses, Xu W, Xia S, Pu J, Wang Q, Li P, Lu L*, Jiang S*, 2018
- Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs, Xu W#, Wang Q#, Yu F, Lu L*, Jiang S*, 2014
- Serological investigation of subclinical influenza A(H7H9) infection among healthcare and non-healthcare workers in Zhejiang Province, China, Xu W#, Lu L#, Shen B, Li J, Xu J, Jiang S*, 2013
Awards
- 2013: 'One Health' Fund, Shanghai Medical College, Fudan University
